Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2009
12/03/2009US20090297509 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
12/03/2009US20090297504 Bcma polypeptides and uses thereof
12/03/2009US20090297493 nanoporous particle with a retained target
12/03/2009US20090297489 Method for Expansion of Tumour-Reactive T-Lymphocytes for Immunotherapy of Patients with Cancer
12/03/2009US20090297487 Method for introducing sirna into cells by photochemical internalisation
12/03/2009US20090297483 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
12/03/2009US20090297473 Sulphonylpyrrole Hydrochloride Salts as Histone Deacetylases Inhibitors
12/03/2009US20090297471 Methods For Autologous Stem Cell Transplantation
12/03/2009US20090297456 Swallowtail motifs for imparting water solubility to porphyrinic compounds
12/03/2009US20090297449 Metalloproteinase 9 and metalloproteinase 2 binding proteins
12/03/2009US20090297443 Labeled ALPHA4BETA2 Ligands and Methods Therefor
12/03/2009US20090297440 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides
12/03/2009US20090297438 Human Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA)
12/03/2009US20090297437 Radioactive device
12/03/2009US20090297436 Antibodies to il-6 and use thereof
12/03/2009CA2762314A1 Mechanism of action of primary cell derived biologic
12/03/2009CA2757437A1 Compositions and methods for immunotherapy
12/03/2009CA2726009A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumours
12/03/2009CA2725788A1 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
12/03/2009CA2725603A1 5-substituted isoindoline compounds
12/03/2009CA2725551A1 Methods of treating cancer of the central nervous system
12/03/2009CA2725220A1 Ant-ligands molecules and biological applications
12/03/2009CA2723587A1 Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
12/03/2009CA2723580A1 Modulating interstitial pressure and oncolytic viral delivery and distribution
12/03/2009CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009CA2721851A1 Purine pi3k inhibitor compounds and methods of use
12/03/2009CA2721665A1 Compounds including an anti-inflammatory pharmacore and methods of use
12/03/2009CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009CA2719127A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/03/2009CA2719125A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009CA2719118A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a]pyridines, and preparation and therapeutic use thereof
12/03/2009CA2718953A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-.alpha.] pyridines, and preparation and therapeutic use thereof
12/02/2009EP2128272A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor
12/02/2009EP2128267A2 Methods of evaluating phosphatase inhibitors
12/02/2009EP2128261A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof
12/02/2009EP2128248A1 Oligonucleotide compositions with enhanced efficiency
12/02/2009EP2128166A1 Polymorphic forms of Ibandronate sodium and processes for preparation thereof
12/02/2009EP2128160A1 Indolo[2,3-b]-, Indeno[1,2-b]- and Indeno[2,1-b]pyrido[2,3-f] quinoxaline-3-carboxylic acids and esters, processes for their preparation and their use as antiviral, antibiotic and antitumor agents
12/02/2009EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/02/2009EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
12/02/2009EP2127680A1 Use of carbon nanotube for drug delivery.
12/02/2009EP2127671A1 Therapeutic agent for cancer
12/02/2009EP2127652A1 Method for treating cancer using anticancer agent in combination
12/02/2009EP2126136A2 Diagnosis of prostate cancer
12/02/2009EP2126127A2 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
12/02/2009EP2126092A2 Fusion proteins binding to growth factors
12/02/2009EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
12/02/2009EP2125897A2 Monoclonal antibodies for treatment of cancer
12/02/2009EP2125896A2 Anti-robo4 antibodies and uses therefor
12/02/2009EP2125888A1 Method of providing human tumor-specific antibodies
12/02/2009EP2125859A2 Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors
12/02/2009EP2125855A2 Methods and compositions for the treatment of cancer or other diseases
12/02/2009EP2125818A1 New classical antifolates
12/02/2009EP2125809A1 Imidazopyridine inhibitors of iap
12/02/2009EP2125777A1 Spiro substituted compounds as angiogenesis inhibitors
12/02/2009EP2125775A1 Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
12/02/2009EP2125719A1 Bazedoxifene bis-phosphorates
12/02/2009EP2125712A1 Novel protein kinase modulators and therapeutic uses thereof
12/02/2009EP2125697A1 Positively charged water-soluble prodrugs of retinoids and retinoid-like compounds with very high skin penetration rates
12/02/2009EP2125032A1 Treating cancer with viral nucleic acid
12/02/2009EP2125029A2 Construction and use of transfection enhancer elements
12/02/2009EP2125025A2 Multi-functional drug carriers
12/02/2009EP2125023A2 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field
12/02/2009EP2125013A1 Dll4 signaling inhibitors and uses thereof
12/02/2009EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
12/02/2009EP2124948A1 Compositions for treating hyperproliferative vascular disorders and cancers
12/02/2009EP2124943A1 Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
12/02/2009EP2124936A2 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities
12/02/2009EP2124928A1 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors
12/02/2009EP1951274B1 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer
12/02/2009EP1753732B1 Phenyl-sulfamates as aromatase inhibitors
12/02/2009EP1664029B1 Quinazoline derivatives as antitumor agents
12/02/2009EP1626050B1 Sulfur-containing naphthoylimide derivatives
12/02/2009EP1606284B1 Compositions useful as protein kinase inhibitors
12/02/2009EP1581477B1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/02/2009EP1542684B1 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
12/02/2009EP1534670B1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009EP1389203B1 Analogs of thalidomide as angiogenesis inhibitors
12/02/2009EP1370270B1 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
12/02/2009EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009CN101595213A Cancerous disease modifying antibodies
12/02/2009CN101595130A Compositions and methods for the diagnosis and treatment of tumor
12/02/2009CN101595121A Pyrrolydine derivatives as IAP inhibitors
12/02/2009CN101595115A Organo-arsenoxide compounds and use thereof
12/02/2009CN101595107A Substituted piperidines that increase P53 activity and the uses thereof
12/02/2009CN101595103A Pyrimidine derivatives
12/02/2009CN101595098A 1,2,4-triazole derivatives as sigma receptor inhibitors
12/02/2009CN101595095A 18, 21-didesoxymacbecin derivatives for the treatment of cancer
12/02/2009CN101594883A Diagnosis and treatment of cancer using anti-EREG antibody
12/02/2009CN101594862A Substituted indazole derivatives active as kinase inhibitors
12/02/2009CN101594860A Adam inhibitor
12/02/2009CN101591658A ING4 and IL-24 dual gene co-expression vector and application thereof
12/02/2009CN101591657A Thymosin beta4 gene expression inhibiting RNA and use thereof
12/02/2009CN101591656A Sequences of small interfering RNAs blocking expression of macophagemigration inhibitory factor
12/02/2009CN101591649A Methoxypolyethylene glycol-modified arginine deiminase, preparation thereof and use thereof
12/02/2009CN101591601A Health-care wine
12/02/2009CN101591397A Recombinant expression and application of long-acting thymosin alpha1
12/02/2009CN101591396A Anti-erbB2 human antibody MIL-5 and application thereof
12/02/2009CN101591395A Human single chain antibody and application of antitumor vascular endothelium marker molecule 8-cell outer region
1 ... 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 ... 2211